Stepan Co: Form 10-Q for the period ended Mar 31, 2011
Filed with the SEC on May 5, 2011 and accepted by EDGAR at May 5, 2011, 10:17 ET.
Management's discussion and analysis
As filed, 38,215 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following is management’s discussion and analysis of certain significant factors that have affected the Company’s financial condition and results of operations during the interim period included in the accompanying condensed consolidated financial statements.
Except for the historical statements contained in this report, the matters discussed in the following discussion and analysis are forward-looking statements that are subject to certain risks, uncertainties and assumptions. Such forward-looking statements are intended to be identified in this document by the words, “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “objective,” “outlook,” “plan,” “project,” “possible,” “potential,” “should” and similar expressions. Actual results may vary materially.
Forward-looking statements speak only as of the date they are made, and the Company does not undertake any obligation to update them to reflect changes that occur after that date. Factors that could cause actual results to differ materially include the items described in Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2010.
Overview
The Company produces and sells intermediate chemicals that are used in a wide variety of applications worldwide. The overall business comprises three reportable segments:
- Surfactants – Surfactants, which accounted for 77 percent of consolidated net sales for the first quarter of 2011, are principal ingredients in consumer and industrial cleaning products such as detergents for washing clothes, dishes, carpets, floors and walls, as well as shampoos, body washes, toothpastes and fabric softeners. Other applications include germicidal quaternary compounds, lubricating ingredients, emulsifiers (for spreading agricultural products), plastics and composites and biodiesel. Surfactants are manufactured at six North American sites (five in the U.S. and one in Canada), three European sites (United Kingdom, France and Germany), three Latin American sites (Mexico, Brazil and Colombia) and one Asian site (Philippines; the Company acquired controlling interest in Stepan Philippines Inc. (SPI) on July 19, 2010). Also in the third quarter of 2010, the Company purchased assets in Singapore and initiated the development of a methyl esters plant in that location. Completion of the Singapore plant is expected in the second quarter of 2012. The Company also holds a 50 percent ownership interest in a joint venture, TIORCO, LLC (TIORCO), that markets chemical solutions for increasing the production of crude oil and natural gas from existing fields. The joint venture is accounted for under the equity method, and its financial results are excluded from surfactant segment operating results.
- Polymers – Polymers, which accounted for 20 percent of consolidated net sales for the first quarter of 2011, include two primary product lines: polyols and phthalic anhydride. Polyols are used in the manufacture of rigid laminate insulation board for thermal insulation in the construction industry. Polyols are also a base raw material for flexible foams, coatings, adhesives, sealants and elastomers. Phthalic anhydride is used in unsaturated polyester resins, alkyd resins and plasticizers for applications in construction materials and components of automotive, boating and other consumer products. In addition, phthalic anhydride is used internally in the production of polyols. In the U.S., polymer product lines are manufactured at the Company’s Millsdale, Illinois, site. In Europe, polyols are manufactured at the Company’s subsidiaries in Germany and Poland. The Poland entity was acquired in the third quarter of 2010. Polyols are also produced at the Company’s 80-percent owned joint venture in Nanjing, China.
- Specialty Products – Specialty products, which accounted for three percent of consolidated net sales for the first quarter of 2011, include flavors, emulsifiers and solubilizers used in the food and pharmaceutical industries. Specialty products are primarily manufactured at the Company’s Maywood, New Jersey, site.
Deferred Compensation Plans
The accounting for the Company’s deferred compensation plans can cause period-to-period fluctuations in Company expenses and profits. Compensation income results when the value of Company common stock held for the plans declines, and compensation expense results when the value of Company common stock increases. The pretax effect of all deferred compensation-related activities (including realized and unrealized gains and losses on the mutual fund assets held to fund the deferred compensation obligations) and the income statement line items in which the effects of the activities were recorded are displayed below:
(In millions)
| Income For the Three Months Ended March 31 2011 | 2010 | Increase (Decrease) | ||
|---|---|---|---|---|
| Deferred Compensation (Administrative expense) | $0.4 | $1.8 | ($ | 1.4 ) (1) |
| Realized/Unrealized Gains on Investments (Other, net) | 0.5 | 0.4 | 0.1 | |
| Pretax Income Effect | $0.9 | $2.2 | ($ | 1.3) |
(1) The value of Company common stock declined $3.77 per share from $76.27 per share at December 31, 2010, to $72.50 per share at March 31, 2011. For the first quarter of 2010, the Company’s common stock price declined $8.92 per share from $64.81 per share at December 31, 2009, to $55.89 per share at March 31, 2010.
Effects of Foreign Currency Translation
The Company’s foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results). For the quarter ended March 31, 2011, except for the European euro, the U.S. dollar weakened against all the foreign currencies in the locations where the Company does business, when compared to the exchange rates for the quarter ended March 31, 2010. Consequently, reported net sales, expense and income amounts for the first quarter of 2011 were higher than they would have been had the foreign currency exchange rates remained constant with the rates for the first quarter of 2010. The following table presents the effect that foreign currency translation had on the quarter-over-quarter changes in consolidated net sales and various income line items for the quarter ended March 31, 2011:
(In millions)
| Three Months Ended March 31 2011 | 2010 | Increase (Decrease) | Increase Due to Foreign Translation | |
|---|---|---|---|---|
| Net Sales | $422.6 | $337.0 | $85.6 | $3.5 |
| Gross Profit | 61.8 | 63.6 | (1.8) | 0.4 |
| Operating Income | 29.9 | 33.7 | (3.8) | 0.3 |
| Pretax Income | 27.1 | 31.6 | (4.5) | 0.2 |
RESULTS OF OPERATIONS
Three Months Ended March 31, 2011 and 2010
Summary
Net income attributable to the Company for the first quarter of 2011 declined nine percent to $18.8 million, or $1.68 per diluted share, compared to $20.7 million, or $1.88 per diluted share, for the first quarter of 2010. Below is a summary discussion of the major factors leading to the quarter-over-quarter changes in net sales, profits and expenses. A detailed discussion of segment operating performance for the first quarter of 2011 follows the summary.
Consolidated net sales increased $85.6 million, or 25 percent, quarter over quarter. Higher average selling prices, higher sales volume and the effects of foreign currency translation accounted for approximately $70.1 million, $12.0 million and $3.5 million, respectively, of the increase. The rise in average selling prices was primarily attributable to price increases resulting from higher quarter-over-quarter raw material costs. Sales volume improved four percent, reflecting increases for all three segments.
Operating income for the first quarter of 2011 was $3.8 million lower (11 percent) than operating income for the first quarter of 2010. Gross profit declined $1.8 million, or three percent. Rising raw material costs led to lower margins in Europe and for the Company’s specialty products segment. The effects of foreign currency translation reduced the gross profit decline by about $0.4 million.
Operating expenses increased $2.0 million, or seven percent, between quarters due primarily to the following:
- Administrative expenses increased $1.8 million, or 20 percent, due largely to a $1.4 million decrease in deferred compensation income. The reduction in deferred compensation income resulted primarily from changes in the price of Company common stock to which a large part of the deferred compensation obligation is tied. See the ‘Overview’ and ‘Corporate Expenses’ sections of this management discussion and analysis for further details. A $0.3 million increase in consulting expenses contributed to the higher administrative expenses.
- Marketing expenses declined $0.1 million, or one percent, quarter over quarter. Bad debt expense declined $0.5 million, which reflected lower provision requirements for high-risk customers throughout the Company’s global organization. The lower bad debt expense was largely offset by expenses for the Philippines and Poland subsidiaries (that were first consolidated in the third quarter of 2010) and the unfavorable effects of foreign currency translation.
- Research, development and technical service expenses were up $0.3 million, or four percent, quarter over quarter.
Interest expense, net for the first quarter of 2011 was up $0.8 million, or 64 percent, over interest expense for the first quarter of 2010. Higher average debt levels led to the increase. In the second quarter of 2010, the Company secured $40 million of additional long-term notes to take advantage of the low interest rate environment and to support global growth initiatives.
The loss from equity joint ventures, which included results for TIORCO for the first quarter of 2011 compared to results for TIORCO and SPI for the first quarter of 2010 (the Company acquired controlling interest of SPI in the third quarter of 2010), increased $0.4 million quarter over quarter. The equity loss in TIORCO increased $0.2 million and the first quarter of last year included SPI equity income of $0.2 million. The Company also sells surfactant products to TIORCO and its customers. The sales and resulting income from the sales are included in the Company’s surfactants segment operating results.
Other, net was $0.3 million of income for the first quarter of 2011 compared to $0.2 million of expense for the first quarter of 2010, a favorable swing of $0.5 million. Foreign exchange losses were down $0.4 million between quarters and investment related income was up $0.1 million.
The effective tax rate was 30.7 percent for the first quarter of 2011 compared to 34.6 percent for the first quarter of 2010. The decrease was primarily attributable to structural changes that will provide a recurring benefit in lowering the effective tax rate on foreign earnings. An increase in U.S. tax credits also contributed to the lower effective tax rate.
Segment Results
(Dollars in thousands)
| For the three months ended March 31, 2011 | Surfactants | Polymers | Specialty Products | Segment Results | Corporate | Total |
|---|---|---|---|---|---|---|
| Net sales | $324,885 | $86,399 | $11,314 | $422,598 | — | $422,598 |
| Operating income | 28,164 | 6,365 | 3,264 | 37,793 | (7,942) | 29,851 |
| For the three months ended March 31, 2010 | ||||||
| Net sales | $262,313 | $63,110 | $11,607 | $337,030 | — | $337,030 |
| Operating income | 29,253 | 6,652 | 4,223 | 40,128 | (6,473) | 33,655 |
Surfactants
Surfactants net sales for the first quarter of 2011 increased $62.6 million, or 24 percent, over net sales for the first quarter of 2010. Higher average selling prices, the effects of foreign currency translation and a one percent increase in sales volume accounted for approximately $56.7 million, $3.6 million and $2.3 million, respectively, of the net sales change. A quarter-over-quarter comparison of net sales by region follows:
(Dollars in thousands)
| For the Three Months Ended March 31, 2011 | March 31, 2010 | Increase | Percent Change | |
|---|---|---|---|---|
| North America | $206,150 | $178,620 | $27,530 | +15 |
| Europe | 77,193 | 59,580 | 17,613 | +30 |
| Latin America | 32,197 | 24,113 | 8,084 | +34 |
| Asia | 9,345 | — | 9,345 | NM |
| Total Surfactants Segment | $324,885 | $262,313 | $62,572 | +24 |
Net sales for North American operations increased 15 percent due to a 21 percent increase in average selling prices and the effects of foreign currency translation, which accounted for $36.2 million and $1.1 million, respectively, of the net sales change. A six percent decline in sales volume reduced the quarter-over-quarter change by $9.8 million. Average selling prices increased primarily as a result of higher costs for all major raw materials. The foreign currency translation effect resulted from the strengthening of the Canadian dollar against the U.S. dollar. Sales volume declined largely due to an eight percent decrease in laundry product volume that was partially offset by improved sales of higher margin functional products. The decline in laundry sales volume was attributable to nonrecurring business in the year ago quarter.
Net sales for European operations increased 30 percent due to a 30 percent increase in average selling prices, which accounted for $17.5 million of the net sales increase. The favorable effects of foreign currency translation added another $0.5 million to the quarter-over-quarter change, largely offset by the effects of a one percent decline in sales volume. Selling price increases made throughout 2010, reflecting higher raw material costs, accounted for the increase in average selling prices.
Net sales for Latin American operations were up 34 percent as a result of a 13 percent increase in sales volume, an 11 percent increase in average selling prices and the favorable effects of foreign currency translation, which accounted for $3.1 million, $3.0 million and $2.0 million, respectively, of the quarter-over-quarter net sales change. Additional business gained throughout 2010 at the Company’s Brazil subsidiary accounted for approximately 70 percent of the sales volume growth. The Mexico and Colombia subsidiaries also contributed to this growth. The increase in average selling prices was attributable to increased raw material costs. The favorable currency translation impact resulted from the strengthening of the currencies for all three Latin American locations against the U.S. dollar.
The $9.3 million of net sales for Asia operations reflected sales by the Company’s Philippines subsidiary, which is now consolidated.
Surfactants operating income for the first quarter of 2011 was $1.1 million lower than operating income for the first quarter of 2010. Gross profit declined $1.0 million due principally to the effects of lower margins in Europe and higher start-up costs in Brazil, partially offset by improved margins in Asia. The effects of foreign currency translation reduced the quarter-over-quarter gross profit decline by $0.4 million. Operating expenses increased $0.1 million, or one percent. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:
(Dollars in thousands)
| Gross Profit | For the Three Months Ended March 31, 2011 | March 31, 2010 | Increase (Decrease) | Percent Change |
|---|---|---|---|---|
| North America | $37,546 | $37,238 | $308 | +1 |
| Europe | 5,701 | 7,067 | (1,366) | -19 |
| Latin America | 3,165 | 4,036 | (871) | -22 |
| Asia | 971 | — | 971 | NM |
| Total Surfactants Segment | $47,383 | $48,341 | $(958) | -2 |
| Operating Expenses | 19,219 | 19,088 | 131 | +1 |
| Operating Income | $28,164 | $29,253 | $(1,089) | -4 |
North American gross profit was up one percent quarter-over-quarter despite lower sales volume. The previously noted increase in average selling prices, coupled with a more favorable mix of sales, helped to offset the impact of the decrease in sales volume. The Company announced selling price increases effective April 1, 2011.
Gross profit for European operations declined 19 percent due largely to the effects of higher raw material costs. The previously mentioned selling price increases did not keep pace with the rapid rise in raw material costs. The decline in sales volume also contributed to the lower gross profit.
Gross profit for Latin American operations was down 22 percent primarily as a result of higher manufacturing costs due to the recent neutralizer capacity expansion in Brazil.
The $1.0 million of gross profit for Asia operations reflected profits earned by the Company’s Philippines subsidiary.
Operating expenses for the surfactants segment were up $0.1 million, or one percent, quarter-over-quarter. Operating expenses for the Singapore and Philippines locations, which were first consolidated in the third quarter of 2010, accounted for $0.5 million of the increase. Lower bad debt expense for the segment offset the Singapore and Philippines expenses by $0.3 million.
Polymers
Polymers net sales for the first quarter of 2011 increased $23.3 million, or 37 percent, from net sales for the same quarter of 2010. A 19 percent improvement in sales volume and higher average selling prices accounted for $12.1 million and $11.3 million, respectively, of the increase. The effects of foreign currency translation were insignificant. A quarter-over-quarter comparison of net sales by region is displayed below:
(Dollars in thousands)
| For the Three Months Ended March 31, 2011 | March 31, 2010 | Increase | Percent Change | |
|---|---|---|---|---|
| North America | $54,189 | $41,973 | $12,216 | +29 |
| Europe | 28,580 | 18,440 | 10,140 | +55 |
| Asia and Other | 3,630 | 2,697 | 933 | +35 |
| Total Polymers Segment | $86,399 | $63,110 | $23,289 | +37 |
Net sales for North American operations increased 29 percent due to a 14 percent increase in average selling prices and a 14 percent increase in sales volume. The increases in average selling prices and sales volume accounted for $6.5 million and $5.7 million, respectively, of the increase in net sales. The higher average selling prices reflected rising raw material costs for all polymer product lines. Sales volume for polyols and phthalic anhydride increased 22 percent and six percent, respectively. The sales volume improvement resulted primarily from increased demand from existing customers, reflecting improvement in the market segments into which the polymer segment sells.
Net sales for European operations grew 55 percent due to a 34 percent increase in sales volume and a 17 percent increase in average selling prices, which accounted for $6.2 million and $4.1 million, respectively, of the net sales improvement. The effects of foreign currency translation reduced the effects of the higher sales volume and prices by $0.2 million. The higher quarter-over-quarter sales volume reflected stronger demand from most major polyol customers and new business gained throughout 2010. In addition, the Company’s Poland subsidiary, which was acquired in the third quarter of 2010, accounted for nine percent of the quarter-over-quarter sales volume growth. Increased raw material costs led to the higher average selling prices.
Asia and Other operations’ net sales were up 35 percent quarter over quarter due to a 15 percent increase in average selling prices coupled with a 13 percent increase in sales volume. Higher raw material costs drove the increase in selling prices, and new business secured by the Company’s China subsidiary led to the quarter-over-quarter growth in sales volume.
Polymer operating income for the first quarter of 2011 declined $0.3 million from operating income for the first quarter of 2010. Gross profit was essentially unchanged quarter-over-quarter, as improvement in gross profit for North American operations was offset by a decline in gross profit for European operations. Operating expenses increased $0.3 million, or six percent, between quarters. Below are quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income:
(Dollars in thousands)
| Gross Profit | For the Three Months Ended March 31, 2011 | March 31, 2010 | Increase (Decrease) | Percent Change |
|---|---|---|---|---|
| North America | $8,560 | $7,442 | $1,118 | +15 |
| Europe | 2,366 | 3,419 | (1,053) | -31 |
| Asia and Other | 183 | 280 | (97) | -35 |
| Total Polymers Segment | $11,109 | $11,141 | $(32) | — |
| Operating Expenses | 4,744 | 4,489 | 255 | +6 |
| Operating Income | $6,365 | $6,652 | $(287) | -4 |
Gross profit for North American operations increased 15 percent due to the 14 percent increase in sales volume noted earlier. Average unit margins were unchanged, as quarter-over-quarter selling price increases essentially equaled quarter-over-quarter average raw material cost increases. The Company announced March 15, 2011, polyol selling price increases to help prevent margin deterioration.
Gross profit for European operations declined 31 percent despite the 34 percent increase in sales volume. The effects of rising raw material costs coupled with the outsourcing of polyols from the segment’s North American operations due to capacity constraints more than offset the favorable impact of the sales volume growth. Selling price increases were made throughout 2010 but have not kept pace with increases in costs. The Company’s project to expand polyol capacity at the segment’s Germany location is scheduled to be completed late in May of 2011.
The decline in gross profit for Asia and Other operations reflected higher raw material costs that more than offset the effect of the 13 percent increase in sales volume.
The $0.3 million increase in operating expenses was attributable to higher marketing expenses for European operations.
Specialty Products
Net sales for the first quarter of 2011 were $0.3 million, or three percent, lower than net sales for the first quarter of 2010. Lower sales volume for products used in health care and pharmaceutical applications led to the decline. Operating income was down $1.0 million, or 23 percent, quarter over quarter due to higher raw material costs and the lower health care and pharmaceutical product sales volume.
Corporate Expenses
Corporate expenses, which comprise operating expenses that are not allocated to the reportable segments, increased $1.4 million (23 percent) to $7.9 million for the first quarter of 2011 from $6.5 million for the first quarter of 2010. Deferred compensation expense accounted for the increase, as the Company recorded $0.4 million of deferred compensation income for the first quarter of 2011 compared to $1.8 million of income for the first quarter of 2010. The value of Company common stock, to which a large portion of the deferred compensation obligation is tied, declined $3.77 per share from $76.27 per share at December 31, 2010, to $72.50 per share at March 31, 2011. For last year’s first quarter, the Company’s common stock price declined $8.92 per share from $64.81 per share at December 31, 2009, to $55.89 per share at March 31, 2010. The accounting for the Company’s deferred compensation plans results in income when the value of Company common stock held in the plans falls and expense when the value of Company common stock increases. The smaller decline in common share price led to less compensation income recorded in the first quarter of 2011 than in the first quarter of 2010.
LIQUIDITY AND CAPITAL RESOURCES
For the first three months of 2011, the Company used $58.4 million of available cash to fund a net operating cash use of $25.4 million, net investing cash uses of $22.7 million and net financing cash outflows of $11.0 million, with exchange rates increasing cash by $0.7 million. For the first quarter of 2011, net income was down by $1.9 million and working capital consumed $21.3 million more than for the same period in 2010. Investing cash outflows increased by $9.8 million year over year and financing outflows increased by $3.3 million.
For the first quarter of 2011, changes in accounts receivable resulted in a cash use of $63.9 million versus a use of $38.4 million for the year ago quarter. Inventories were a use of $21.0 million compared to a use of $11.2 million in 2010. Accounts payable and accrued liabilities were a source of $31.0 million during 2011 compared to $16.6 million in 2010.
During 2011, the rising cost of raw materials drove higher selling prices to customers which, in turn, required higher working capital growth for the current year quarter compared to the same quarter in 2010. The Company’s working capital investment is heavily influenced by the cost of crude oil and natural oils, from which many of its raw materials are derived. Higher raw material costs translate directly to higher inventory carrying costs and indirectly to customer selling prices and accounts receivable.
The year-to-date accounts receivable increase was driven approximately equally by the combination of higher quarterly sales volumes and higher selling prices, partially offset by improved accounts receivable turnover since year-end. Slightly more than 50 percent of the year-to-date inventory increase resulted from higher raw material costs with the rest attributable to planned increases to support customer service levels. The Company has not changed its own payment practices related to its payables. It is management’s opinion that the Company’s liquidity is sufficient to provide for potential increases in working capital during 2011.
Investing cash outflows for the first three months of 2011 totaled $22.7 million compared to $12.9 million for the same period in 2010. Capital expenditures for the first quarter of 2011 totaled $22.5 million, including higher spending for capacity expansion, compared to $13.0 million for the year-ago quarter. For 2011, the Company estimates that full-year capital spending will range from $85 million to $90 million, including a capacity expansion in Singapore. The estimated range of capital expenditures excludes $12.2 million for the purchase of the Millsdale (Joliet), Illinois, warehouse, which was reflected in financing activities for the current year quarter. Prior to the cash purchase, the warehouse was recorded as an asset on the Company’s balance sheet along with a build-to-suit lease obligation. During 2011 the Company also liquidated $1.5 million of investments for benefit plan participant payouts versus $0.7 million in 2010.
The Company purchases its common shares in the open market from time to time to fund its own benefit plans and also to mitigate the dilutive effect of new shares issued under its benefit plans. The Company may also make open market repurchases as cash flows permit when, in management’s opinion, the Company’s shares are undervalued in the market. The Company made no open market purchases during the first quarter of 2011. At March 31, 2011, there were 250,715 shares remaining under the current share repurchase authorization.
At March 31, 2011, the Company’s cash and cash equivalents totaled $52.7 million, including $22.3 million in two U.S. money market funds, each of which was rated AAA by Standard and Poor’s and Aaa by Moody’s. Cash in U.S. demand deposit accounts totaled $13.8 million and cash of the Company’s non-U.S. subsidiaries held outside the U.S. totaled $16.6 million as of March 31, 2011.
Total Company debt decreased by $5.9 million during the first quarter of 2011, from $191.6 million to $185.7 million, reflecting an increase of $5.5 million in foreign debt and a decrease of $11.4 million in U.S. debt. The increase in foreign debt was driven primarily by working capital requirements in Europe. The decrease in U.S. debt reflected the liquidation of the previously noted build-to-suit lease obligation. Net debt (which is defined as total debt minus cash) increased by $52.5 million for the first three months of 2011, from $80.4 million to $132.9 million. At March 31, 2011, the ratio of total debt to total debt plus shareholders’ equity was 33.0 percent, compared to 35.2 percent at December 31, 2010. The ratio of net debt to net debt plus shareholders’ equity was 26.0 percent at March 31, 2011, compared to 18.5 percent at December 31, 2010.
As of March 31, 2011, the Company’s debt included $106.9 million of unsecured private placement loans with maturities extending from 2011 through 2022. These loans are the Company’s primary source of long-term debt financing, and are supplemented by bank credit facilities to meet short and medium term needs. The Company’s debt also included a $27.0 million term loan with its U.S. banks, which has maturities from 2011 through 2013.
The Company maintains a committed $60.0 million revolving credit agreement with three U.S. banks. This unsecured facility is the Company’s primary source of short-term borrowings and is committed through August 27, 2013 with terms and conditions that are substantially equivalent to those of the Company’s other U.S. loan agreements. As of March 31, 2011, the Company had outstanding letters of credit of $2.6 million and no outstanding debt under this agreement, with $57.4 million remaining available. The Company anticipates that cash from operations, committed credit facilities and cash on hand will be sufficient to fund anticipated capital expenditures, working capital, dividends and other planned financial commitments for the foreseeable future.
Certain foreign subsidiaries of the Company maintain term loans and short-term bank lines of credit in their respective local currencies to meet working capital requirements as well as to fund capital expenditure programs and acquisitions. As of March 31, 2011, the Company’s European subsidiaries had bank term loans of $6.4 million with maturities through 2015 and short-term bank debt of $22.7 million with available short-term borrowing capacity of $16.0 million. The Company’s Latin American subsidiaries had no outstanding debt, with $9.9 million of short-term borrowing capacity as of that date. As of March 31, 2011, the Company’s Singapore subsidiary was obligated for $13.3 million under an asset purchase agreement that took effect on November 4, 2010. The Company’s majority-owned joint ventures in the Philippines and China had debt totaling $9.4 million and available borrowing capacity of $8.7 million. Stepan Company has guaranteed the debt obligations of its Singapore subsidiary and of its majority-owned joint ventures in the Philippines and China.
The Company has material debt agreements that require the maintenance of minimum interest coverage and minimum net worth. These agreements also limit the incurrence of additional debt as well as the payment of dividends and repurchase of treasury shares. Testing for these agreements is based on the combined financial statements of the U.S. operations of Stepan Company and Stepan Canada Inc. (the “Restricted Group”). Under the most restrictive of these debt covenants:
1. The Restricted Group must maintain a minimum interest coverage ratio, as defined within the agreements, of 2.0 to 1.0, for the preceding four calendar quarters.
2. The Restricted Group must maintain net worth of at least $175.0 million.
3. The Restricted Group must maintain a ratio of long-term debt to total capitalization, as defined in the agreements, not to exceed 55 percent.
4. The Restricted Group may pay dividends and purchase treasury shares in amounts of up to $30.0 million plus 100 percent of net income and cash proceeds of stock option exercises, measured cumulatively after December 31, 2001. The maximum amount of dividends that could have been paid within this limitation is disclosed as unrestricted retained earnings in Note 12, Debt, in the Notes to Consolidated Financial Statements.
The Company was in compliance with all of its loan agreements as of March 31, 2011. Based on current projections, the Company believes it will be in compliance with its loan agreements throughout 2011.
ENVIRONMENTAL AND LEGAL MATTERS
The Company is subject to extensive federal, state and local environmental laws and regulations. Although the Company’s environmental policies and practices are designed to ensure compliance with these laws and regulations, future developments and increasingly stringent environmental regulation could require the Company to make additional unforeseen environmental expenditures. The Company will continue to invest in the equipment and facilities necessary to comply with existing and future regulations. During the first three months of 2011 and 2010, the Company’s expenditures for capital projects related to the environment were $0.2 million. These projects are capitalized and depreciated over their estimated useful lives, which is typically 10 years. Recurring costs associated with the operation and maintenance of facilities for waste treatment and disposal and managing environmental compliance in ongoing operations at the Company’s manufacturing locations were $3.8 million for the three months ended March 31, 2011 and 2010, respectively. While difficult to project, it is not anticipated that these recurring expenses will increase significantly in the future.
Over the years, the Company has received requests for information related to or has been named by the government as a potentially responsible party at a number of waste disposal sites where cleanup costs have been or may be incurred under CERCLA and similar state statutes. In addition, damages are being claimed against the Company in general liability actions for alleged personal injury or property damage in the case of some disposal and plant sites. The Company believes that it has made adequate provisions for the costs it may incur with respect to the sites. It is the Company’s accounting policy to record liabilities when environmental assessments and/or remedial efforts are probable and the cost or range of possible costs can be reasonably estimated. When no amount within the range is a better estimate than any other amount, the minimum is accrued. Some of the factors on which the Company bases its estimates include information provided by feasibility studies, potentially responsible party negotiations and the development of remedial action plans. After partial remediation payments at certain sites, the Company has estimated a range of possible environmental and legal losses of $10.1 million to $29.4 million at March 31, 2011, compared to $10.0 million to $29.7 million at December 31, 2010. At March 31, 2011 and December 31, 2010, the Company’s accrued liability for such losses, which represented the Company’s best estimate within the estimated range of possible environmental and legal losses, was $15.9 million. Actual costs could differ from the estimated reported liability. During the first three months of 2011, cash outlays related to legal and environmental matters approximated $0.7 million compared to $0.6 million for the first three months of 2010.
For certain sites, estimates of the total costs of compliance or the Company’s share of such costs cannot be determined; consequently, the Company is unable to predict the effect thereof on the Company’s financial position, cash flows and results of operations. Management believes that in the event of one or more adverse determinations in any annual or interim period, the impact on the Company’s cash flows and results of operations for those periods could be material. However, based upon the Company’s present belief as to its relative involvement at these sites, other viable entities’ responsibilities for cleanup and the extended period over which any costs would be incurred, the Company believes that these matters will not have a material effect on the Company’s financial position. Certain of these matters are discussed in Item 1, Part 2, Legal Proceedings, in this report and in other filings of the Company with the Securities and Exchange Commission, which are available upon request from the Company. See also Note 7 to the condensed consolidated financial statements for a summary of the environmental proceedings related to certain environmental sites.
OUTLOOK
In order to accelerate its growth, the Company has made investments in faster growing markets in Brazil, Poland, Singapore and Germany, which have led to planned higher operating expenses. The Brazil expansion is complete and volume should ramp up over the second and third quarters. The German polyol expansion will start up during the second quarter and contribute to profit improvement during the third quarter.
The Company has increased its selling prices to address rising raw material costs and remains optimistic about its prospects for volume growth and margin improvement over the remainder of the year. Surfactant earnings improvement will be led by unit margin improvement, improved sales mix of higher margin functional surfactants and volume growth in Brazil. The rise in crude oil prices will stimulate demand for surfactants used in enhanced oil recovery. Polymer demand exceeded expectations in the first quarter, which should lead to further growth in the summer roof replacement season. While 2011 will have additional start up costs associated with new or expanded plants, the Company has the opportunity to deliver full year earnings growth.
CRITICAL ACCOUNTING POLICIES
There have been no changes to the critical accounting policies disclosed in the Company’s 2010 Annual Report on Form 10-K.
Controls and procedures
As filed, 729 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
a. Evaluation of Disclosure Controls and Procedures
Based on their evaluation of our disclosure controls and procedures as of the end of the most recent fiscal quarter covered by this Form 10-Q, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934) were effective as of March 31, 2011.
b. Changes in Internal Control Over Financial Reporting
There were no changes in internal controls that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Source: SEC EDGAR, the filing index for accession 0001193125-11-127626. Last ingested by Listed: Nov 10, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.